Source: China – South China Morning PostThe test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s disease, said the head of Fujirebio Holdings.Read More
Source: China – South China Morning PostThe test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s disease, said the head of Fujirebio Holdings.Read More